Abdominal myomectomy as a treatment for symptomatic uterine fibroids.

Using the previously described approach, I find abdominal myomectomy in general to be a procedure quite comparable with other major pelvic procedures, such as hysterectomy. My postoperative course is associated with a 12% complication rate, the majority of which represents transient febrile morbidity, which resolves quite promptly. In addition, my transfusion rate is 3% or less and my postoperative length of stay is 2 to 3 days. This is consistent with other currently reported series and in my estimation justifies the continued philosophy of offering abdominal myomectomy as a primary treatment for symptomatic uterine fibroids regardless of future childbearing options.